Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
For Research Use Only This product is sold strictly for laboratory and in-vitro research by qualified professionals
Our study is consistent with previous research, revealing that Triple-negative status, Lymphovascular invasion, and Ki67 30% are risk factors for recurrence after chemotherapy
(Under the brand name Victoza, liraglutide is FDA-approved to manage type 2 diabetes)
PAN Foundation Obesity Fund: An independent nonprofit that provides up to $1,000 in grants toward obesity medication costs
The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model
US$ 25.41
US$ 20.36
US$ 29.68
US$ 29.39
US$ 20.26
